2-Chlorobutyric Acid | CAS:4170-24-5

We serve 2-Chlorobutyric Acid CAS:4170-24-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Chlorobutyric Acid

Chemical Name: : 2-Chlorobutyric Acid
CAS.NO:4170-24-5
Synonyms: 
Butanoic acid, 2-chloro-
2-Chlorobutyric acid

Molecular Formula: C4H7ClO2
Molecular Weight:122.55000

Physical and Chemical Properties:
Density: 1.19
Boiling point: 90-92ºC (12 mmHg)
Melting point:/
Flash point: 76.7ºC
Refractive index: 1.439

Specification:
Appearance:
Light yellow liquid
Purity:≥99%
Moisture Content: less than 0.3%
Impurity: less than 0.3%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Levetiracetam  CAS:102767-28-2



Contact us for information like 2-Chlorobutyric Acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chlorobutyric acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Chlorobutyric acid Use and application,2-Chlorobutyric acid technical grade,usp/ep/jp grade.


Related News: At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs.2-FLUORO-3-(TRIFLUOROMETHYL)BENZOIC ACID manufacturer A system that allows Chinese citizens to enter South Korea’s Jeju Island without a visa is to be temporarily suspended.3-amino-4-cyclobutyl-2-hydroxybutanamide supplier This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician’s Choice plus Best Supportive Care.1-Pyrenylboronic acid vendor Jo Soden, Co-managing Director of Retrogenix, said “We look forward to working with Resonant to deconvolute the targets for their antibodies. Resonant’s innovative platform is delivering functional therapeutic candidates at rapid pace and we welcome the opportunity to identify the specific, biologically-relevant targets which will help progress these leads towards promising new therapies for patients with cancer.”He told Sky News: “SARS and MERS are the two severe coronaviruses. There are four that are very mild that people can get very regularly.”